Institutional & Family Asset Management’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Institutional & Family Asset Management’s Portfolio BCLI Stock Details BCLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$2.03K	Hold	400	–	–	﹤0.01%	578
2024 Q1	$3.39K	Hold	400	–	–	﹤0.01%	535
2023 Q4	$1.64K	Hold	400	–	–	﹤0.01%	574
2023 Q3	$1.2K	Buy	400 +200	+100%	+$4.55K	﹤0.01%	599
2023 Q2	$6.18K	Hold	200	–	–	﹤0.01%	450
2023 Q1	$9.9K	Hold	200	–	–	﹤0.01%	381
2022 Q4	$4.92K	Hold	200	–	–	﹤0.01%	476
2022 Q3	$13K	Hold	200	–	–	﹤0.01%	350
2022 Q2	$8K	Hold	200	–	–	﹤0.01%	412
2022 Q1	$10K	Hold	200	–	–	﹤0.01%	436
2021 Q4	$12K	Hold	200	–	–	﹤0.01%	416
2021 Q3	$10K	Hold	200	–	–	﹤0.01%	540
2021 Q2	$11K	Buy	200 +67	+50%	+$3.58K	﹤0.01%	570
2021 Q1	$8K	Hold	133	–	–	﹤0.01%	597
2020 Q4	$9K	Hold	133	–	–	﹤0.01%	551
2020 Q3	$34K	Hold	133	–	–	0.01%	332
2020 Q2	$22K	Hold	133	–	–	﹤0.01%	389
2020 Q1	$9K	Hold	133	–	–	﹤0.01%	461
2019 Q4	$9K	Hold	133	–	–	﹤0.01%	513
2019 Q3	$8K	Hold	133	–	–	﹤0.01%	500
2019 Q2	$8K	Hold	133	–	–	﹤0.01%	522
2019 Q1	$9K	Hold	133	–	–	﹤0.01%	511
2018 Q4	$7K	Hold	133	–	–	﹤0.01%	524
2018 Q3	$8K	Hold	133	–	–	﹤0.01%	550
2018 Q2	$8K	Hold	133	–	–	﹤0.01%	554
2018 Q1	$6K	Buy	+133	New	+$6.7K	﹤0.01%	571

Other funds holding BCLI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LWM

Liberty Wealth Management Oakland, California $800M AUM 22.73% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

AHB

Abner Herrman & Brock Jersey City, New Jersey $1.05B AUM 42.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Institutional & Family Asset Management's BCLI Position: Q2 2024 in Review

Institutional & Family Asset Management held its BRAINSTORM CELL THERAPUTC (BCLI) position steady in Q2 2024 at 400 shares worth $2.03K. The position accounts for ﹤0.01% of the portfolio, ranked #578.

Institutional & Family Asset Management first reported a position in BCLI in Q1 2018 and has held it in 26 quarters since. The position peaked at $34K in Q3 2020. 48 funds tracked by Wall St. Rank hold BCLI as of Q2 2024.

Institutional & Family Asset Management held 400 shares of BRAINSTORM CELL THERAPUTC worth $2.03K as of Q2 2024.
Institutional & Family Asset Management left its BRAINSTORM CELL THERAPUTC share count unchanged in Q2 2024.
BRAINSTORM CELL THERAPUTC made up ﹤0.01% of Institutional & Family Asset Management's portfolio in Q2 2024, its #578 holding.
Institutional & Family Asset Management first reported a position in BRAINSTORM CELL THERAPUTC in Q1 2018 and has held it in 26 quarters since.
Institutional & Family Asset Management's BRAINSTORM CELL THERAPUTC position peaked at $34K in Q3 2020.
48 funds tracked by Wall St. Rank held BRAINSTORM CELL THERAPUTC as of Q2 2024.

Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.